Mechanisms of Coronavirus Genome Stability As Potential Targets for Antiviral Drugs

被引：0
|
作者：
S. K. Yuyukina
D. O. Zharkov
机构：
[1] Institute of Chemical Biology and Fundamental Medicine,
[2] Siberian Branch,undefined
[3] Russian Academy of Sciences,undefined
[4] Novosibirsk State University,undefined
来源：
Herald of the Russian Academy of Sciences | 2022年 / 92卷
关键词：
COVID-19; SARS-CoV-2; nucleoside inhibitors; replication; genome stability; RNA-dependent RNA polymerase; corrective exonuclease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：470 / 478
页数：8
相关论文
共 50 条
  • [31] Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets
    Yapasert, Rittibet
    Khaw-on, Patompong
    Banjerdpongchai, Ratana
    MOLECULES, 2021, 26 (24):
  • [32] Human Papillomavirus G-Rich Regions as Potential Antiviral Drug Targets
    Carvalho, Josue
    Lopes-Nunes, Jessica
    Cabral Campello, Maria Paula
    Paulo, Antonio
    Milici, Janice
    Meyers, Craig
    Mergny, Jean-Louis
    Salgado, Gilmar F.
    Queiroz, Joao A.
    Cruz, Carla
    NUCLEIC ACID THERAPEUTICS, 2021, 31 (01) : 68 - 81
  • [33] Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)
    Nadeem, Muhammad Shahid
    Zamzami, Mazin A.
    Choudhry, Hani
    Murtaza, Bibi Nazia
    Kazmi, Imran
    Ahmad, Habib
    Shakoori, Abdul Rauf
    PATHOGENS, 2020, 9 (04):
  • [34] Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin
    Qin, Xingyue
    Huang, Chen
    Wu, Ka
    Li, Yu
    Liang, Xiao
    Su, Min
    Li, Rong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (02) : 677 - 685
  • [35] Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID-19 pharmacological targets since the outbreak of the pandemic
    Vlachakis, Dimitrios
    Papakonstantinou, Eleni
    Mitsis, Thanasis
    Pierouli, Katerina
    Diakou, Io
    Chrousos, George
    Bacopoulou, Flora
    FOOD AND CHEMICAL TOXICOLOGY, 2020, 146
  • [36] Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs
    Xie, Dafei
    He, Song
    Han, Lu
    Wu, Lianlian
    Huang, Hai
    Tao, Huan
    Zhou, Pingkun
    Shi, Xunlong
    Bai, Hui
    Bo, Xiaochen
    BRIEFINGS IN BIOINFORMATICS, 2022, 23 (03)
  • [37] A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets
    Kratzel, Annika
    Kelly, Jenna N.
    V'kovski, Philip
    Portmann, Jasmine
    Brueggemann, Yannick
    Todt, Daniel
    Ebert, Nadine
    Shrestha, Neeta
    Plattet, Philippe
    Staab-Weijnitz, Claudia A.
    von Brunn, Albrecht
    Steinmann, Eike
    Dijkman, Ronald
    Zimmer, Gert
    Pfaender, Stephanie
    Thiel, Volker
    PLOS BIOLOGY, 2021, 19 (12)
  • [38] Computational Screening to Predict MicroRNA Targets in the Flavivirus 3′ UTR Genome: An Approach for Antiviral Development
    Avila-Bonilla, Rodolfo Gamaliel
    Salas-Benito, Juan Santiago
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [39] Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs
    Ishola, Ahmed A.
    Adewole, Kayode E.
    Tijjani, Habibu
    Abdulai, Suliat, I
    Asogwa, Nnaemeka T.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (17): : 7726 - 7743
  • [40] The Potential Mechanisms Behind Adverse Effect of Coronavirus Disease-19 on Heart and Liver Damage: A Review
    Daba, Tolessa Muleta
    Mokonon, Mulatu
    Niguse, Elsa
    Getahun, Meron
    ETHIOPIAN JOURNAL OF HEALTH SCIENCES, 2024, 34 (01) : 85 - 100
12345